Alkalinized lidocaine
PreclinicalSmall molecule
Alkalinized lidocaine is one of 4 small molecule programs targeting Remifentanil. It is currently in Preclinical.
2
Indications
5
Total Trials
0
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
8 competitors in Local Anesthetic
#DrugCompanyPhaseTrials
1Glucophage
EMD SeronoApproved
Liposomal Bupivacaine
TTLC Biopharmaceuticals, Inc.
Phase 2
Alkalinized lidocaine
MMassachusetts General Hospital
Preclinical
Phenol
NNorthwestern University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Lidocaine2 trials
Remifentanil1 trial
Efficacy of Alkalinized Lidocaine Compared to Remifentanil on the Incidence of Coughing During Emergence of Anesthesia
Completed·—·N/A·NCT01451840·85 enrolled
Local Anesthetic1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Alkalinized lidocaine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- MMassachusetts General Hospital